In late March, as Covid-19 forced educational institutions across the country to shut down most of their ongoing research activities, Rutgers announced the formation of a university hub known as the Covid-19 Center for Response and Pandemic Preparedness. Like the country’s other great research universities, Rutgers called on scientists across an array of its own institutions—including the Institute for Infectious and Inflammatory Diseases; the Institute for Translational Medicine and Science; Rutgers New Jersey Medical School; Rutgers Cancer Institute of New Jersey; and schools of pharmacy, public health, engineering, computational science, social sciences and others—to focus on learning more about SARS-CoV-2 and to develop treatments for the disease it causes. To read the full story.
Recent Posts
- Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains.
- Join NJ ACTS for a Special Lecture on 12/19, 12-1:30
- NJIT Researcher Uses Nanoparticles to Develop Cancer Therapies.
- Researchers Suggest Stress Hormones Explain How Obesity Causes Diabetes.
- Rutgers Study Reveals Vaccination Patterns Among LGBTQ+ Adults in New Jersey and New York.
Categories
- Community (2,077)
- Covid (979)
- CTO Events (5)
- News (2,638)
- Pilots (20)